Namir Shaabani

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Respiratory Syndrome Coronavirus

Inflammatory Response

Silver Nanoparticles

Top Venues

Science signaling

Science advances

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Fangzhu Zhao, Meng Yuan, Celina Keating, Namir Shaabani, Oliver Limbo, Collin Joyce, Jordan L Woehl, Shawn Barman, Alison Burns, Quoc Tran, Xueyong Zhu, Michael J Ricciardi, Linghang Peng, Jessica Smith, Deli Huang, Bryan Briney, Devin Sok, David Nemazee, John R Teijaro, Ian A Wilson, Dennis R Burton, Joseph G Jardine
Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution. Science signaling 16 (798) (2023)
Panpan Zhou, Meng Yuan, Sophie Ge Song, Nathan Beutler, Namir Shaabani, Deli Huang, Wan-Ting He, Xueyong Zhu, Sean Callaghan, Peter Yong, Fabio Anzanello, Linghang Peng, James Ricketts, Mara Parren, Elijah Garcia, Stephen A Rawlings, Davey M Smith, David Nemazee, John R Teijaro, Thomas F Rogers, Ian A Wilson, Dennis R Burton, Raiees Andrabi
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection. Science translational medicine 14 (637) (2022)
Malina A Bakowski, Nathan Beutler, Karen C Wolff, Melanie G Kirkpatrick, Emily Chen, Tu-Trinh H Nguyen, Laura Riva, Namir Shaabani, Mara Parren, James Ricketts, Anil K Gupta, Kastin Pan, Peiting Kuo, MacKenzie Fuller, Elijah Garcia, John R Teijaro, Linlin Yang, Debashis Sahoo, Victor Chi, Edward Huang, Natalia Vargas, Amanda J Roberts, Soumita Das, Pradipta Ghosh, Ashley K Woods, Sean B Joseph, Mitchell V Hull, Peter G Schultz, Dennis R Burton, Arnab K Chatterjee, Case W MacNamara, Thomas F Rogers
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions. Nature communications 12 (1) (2021)
Zhe Huang, Seung Goo Kang, Yunqiao Li, Jaroslav Zak, Namir Shaabani, Kaiyuan Deng, Jovan Shepherd, Raag Bhargava, John R Teijaro, Changchun Xiao
IFNAR1 signaling in NK cells promotes persistent virus infection. Science advances 7 (13) (2021)
Paul David, Malgorzata Drabczyk-Pluta, Eva Pastille, Torben Knuschke, Tanja Werner, Nadine Honke, Dominik A Megger, Ilseyar Akhmetzyanova, Namir Shaabani, Annette Eyking-Singer, Elke Cario, Olivia Kershaw, Achim D Gruber, Matthias Tenbusch, Kirsten K Dietze, Mirko Trilling, Jia Liu, Dirk Schadendorf, Hendrik Streeck, Karl S Lang, Youhua Xie, Lisa Zimmer, Barbara Sitek, Annette Paschen, Astrid M Westendorf, Ulf Dittmer, Gennadiy Zelinskyy
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology. PLoS pathogens 16 (3) (2020)
Namir Shaabani, Nadine Honke, Nhan Nguyen, Zhe Huang, Kei-Ichiro Arimoto, Daniel C Lazar, Taylor K Loe, Karl S Lang, Marco Prinz, Klaus-Peter Knobeloch, Dong-Er Zhang, John R Teijaro
The probacterial effect of type I interferon signaling requires its own negative regulator USP18. Science immunology 3 (27) (2019)